Skip to main content

Professor Lybecker to Report on Counterfeit Medicines in Paris

Colorado College Associate Professor of Economics Kristina Lybecker has been asked by the Organization for Economic Co-operation and Development (OECD ) to prepare a report on the illicit trade in counterfeit medicines. The OECD is leading a Task Force on Charting Illicit Trade, and Lybecker will present the paper at the OECD conference on March 30 in Paris.

"Masquerading as curative medicines, counterfeit pharmaceuticals are increasingly prevalent and increasingly profitable," Lybecker said. "In addressing the threat of counterfeit drugs, there is obvious scope for benefiting both consumers and international pharmaceutical firms. In light of the more public and more aggressive campaign against counterfeiting, it is important to examine extent of the problem, what is known about counterfeit production and distribution, the economic and health consequences of counterfeit drugs, and links to organized crime and the policy responses that have been particularly effective."

Her paper reviews each of these issues, as well as new policy initiatives that appear promising. Lybecker, whose dissertation was titled "Counterfeit Pharmaceuticals: Product Piracy and the Transition to Stronger Intellectual Property Rights in Developing Countries," earned a Ph.D. in economics from the University of California-Berkeley.

Report an issue - Last updated: 12/16/2020